Xencor (XNCR) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Xencor (XNCR) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 29.47% |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - | 78.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.40% |
| Dec 31, 2025 | 27.01% |
| Sep 30, 2025 | 29.82% |
| Jun 30, 2025 | 26.28% |
| Mar 31, 2025 | -28.64% |
| Sep 30, 2024 | 11.06% |
| Jun 30, 2024 | -140.50% |
| Mar 31, 2024 | 43.55% |
| Dec 31, 2023 | -36.27% |
| Sep 30, 2023 | -133.49% |
| Jun 30, 2023 | -0.06% |
| Mar 31, 2023 | -74.62% |
| Dec 31, 2022 | -58.77% |
| Sep 30, 2022 | -98.44% |
| Jun 30, 2022 | -78.37% |
| Mar 31, 2022 | -29.79% |
| Sep 30, 2021 | -415.63% |
| Jun 30, 2021 | 37.00% |
| Mar 31, 2021 | -329.19% |
| Dec 31, 2020 | -80.11% |